Skip to content

Continuous Versus Repetitive Sevoflurane Administration for Preconditioning

A Comparison Between Continuous and Repetitive Sevoflurane Administration for Preconditioning During Coronary Artery Bypass Surgery

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00569816
Enrollment
50
Registered
2007-12-07
Start date
2005-01-31
Completion date
2007-05-31
Last updated
2007-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Injury

Keywords

myocardial protection, pharmacological preconditioning, volatile anesthetics, myocardial injury following CABG surgery

Brief summary

Pharmacologic preconditioning by volatile anesthetics may depend on the mode of administration. The researchers hypothesize that a continuous administration in patients scheduled for CABG surgery prebypass will be less effective in terms of attenuating myocardial cell damage compared to a repetitive administration with a double wash in/wash out schedule. A control group will receive propofol as their primary anesthetic.

Interventions

DRUGSevoflurane

1 MAC Sevoflurane will be given either continuously after induction of anesthesia until initiation of cardiopulmonary bypass or will be repetitively washed in and out twice before initiation of cardiopulmonary bypass.

Sponsors

Department of Anaesthesiology and Intensive Care Medicine
CollaboratorAMBIG
Abbott
CollaboratorINDUSTRY
University Hospital Schleswig-Holstein
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients schedulded to undergo CABG surgery * Age 18 to 80 years * Ejection fraction \> 40%

Exclusion criteria

* Emergency cases * Diabetes * Not able to give informed consent * Ejection fraction \< 40%

Design outcomes

Primary

MeasureTime frame
Myocardial cell damage as assessed by plasma levels of Troponin Tfrom induction of anesthesia until hospital discharge

Secondary

MeasureTime frame
Length of stay on the ICU and in the hospitalfrom hospital admission until hospital discharge

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026